| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $199.0M | — | +3.3% |
| Cost of Revenue | $118.4M | — | +14.0% |
| Gross Profit | $80.6M | — | -9.2% |
| R&D Expense | $28.5M | — | +5.1% |
| SG&A Expense | $26.8M | — | +54.2% |
| Operating Income | $8.0M | — | -72.7% |
| Pre-tax Income | $10.6M | — | -67.9% |
| Income Tax | $1.4M | — | -68.7% |
| Net Income | $9.2M | — | -67.8% |
| EPS (Basic) | $0.30 | — | -66.3% |
| EPS (Diluted) | $0.30 | — | -65.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $150.8M | +3.7% | -18.0% |
| Short-term Investments | $215.8M | -5.7% | -46.5% |
| Accounts Receivable | $161.8M | -4.0% | -1.9% |
| Inventory | $326.1M | -0.9% | +10.2% |
| Current Assets | $935.7M | -0.8% | -16.0% |
| Total Assets | $1.37B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $18.1M | — | -54.4% |
| Capital Expenditures | $1.8M | — | -62.9% |
| Investing Cash Flow | -$10.6M | — | -126.3% |
| Financing Cash Flow | -$1.4M | — | +93.1% |
| Free Cash Flow | $16.3M | — | -53.2% |
| +2.5% |
| Current Liabilities | $203.9M | +3.2% | +1.8% |
| Total Liabilities | $329.9M | +1.0% | +5.3% |
| Stockholders' Equity | $1.04B | +1.0% | +1.7% |